TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1
JAPAN UROLOGICAL DEVICES MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
PROCEDURE NUMBERS 8
MARKETS INCLUDED 9
KEY REPORT UPDATES 11
VERSION HISTORY 11
RESEARCH METHODOLOGY 12
Step 1: Project Initiation & Team Selection 12
Step 2: Prepare Data Systems and Perform Secondary Research 15
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.1.1 Urinary System 26
2.1.1.1 Male Urinary System 27
2.1.1.2 Female Urinary System 28
2.2 DISEASE TREATMENT AND DIAGNOSTICS 29
2.2.1 Benign Prostatic Hyperplasia 29
2.2.2 Urinary Incontinence 31
2.2.3 Urinary Tract Infections 33
2.2.4 Kidney Stones 34
2.2.5 Bladder Prolapse 36
2.2.6 Overactive Bladder 37
2.2.7 Prostatitis 38
2.2.8 Erectile Dysfunction 40
2.2.9 Cancer 42
2.2.9.1 Prostate Cancer 42
2.2.9.2 Bladder Cancer 43
2.2.10 Indications for Pelvic Organ Prolapse Repair 45
PRODUCT ASSESSMENT 46
3.1 INTRODUCTION 46
3.2 PRODUCT PORTFOLIOS 46
3.2.1 Urinary Incontinence 46
3.2.1.1 Urinary Catheters 46
3.2.1.1.1 Intermittent Catheters 46
3.2.1.1.2 Foley Catheters 47
3.2.1.1.3 Male External Catheters 48
3.2.1.2 Urethral Bulking Agents 49
3.2.1.3 Incontinence Management Devices 50
3.2.1.3.1 Female Incontinence Slings 50
3.2.1.3.2 Male Implantable Devices 51
3.2.1.4 Urine Bags 53
3.2.1.4.1 Leg Bags 53
3.2.1.4.2 Night Bags 53
3.2.2 Pelvic Organ Prolapse Repair 58
3.2.2.1 Autologous tissue as an alternative to vaginal mesh 59
3.2.2.2 Product Matrix for Pelvic Organ Prolapse Repair 60
3.2.3 Stone Management 61
3.2.3.1 ESWL Equipment 61
3.2.3.2 ISWL Equipment 62
3.2.3.3 Holmium Lasers 62
3.2.3.4 Stone Fragment Retrieval Devices 63
3.2.3.5 Ureteral Stents 63
3.2.4 BPH Treatment 67
3.2.4.1 TURP 67
3.2.4.2 TUMT 68
3.2.4.3 TUNA 68
3.2.4.4 Prostatic Stents 69
3.2.4.5 Laser BPH 70
3.2.4.5.1 Photoselective Vaporization of the Prostate (PVP) 71
3.2.4.5.2 Laser Vaporization of the Prostate 72
3.2.4.5.3 Laser Ablation of the Prostate 73
3.2.4.5.4 Laser Resection of the Prostate 73
3.2.4.5.5 Laser Enucleation of the Prostate 74
3.2.5 Erectile Dysfunction 76
3.2.5.1 Penile Implants 76
3.2.5.1.1 Inflatable 76
3.2.5.1.2 Malleable 77
3.2.5.2 Vacuum 77
3.3 REGULATORY ISSUES AND RECALLS 79
3.3.1 Boston Scientific 79
3.3.1.1 Stone Management 79
3.3.1.2 Nephrostomy 81
3.3.2 C. R. Bard (Becton Dickinson) 82
3.3.2.1 Urinary Incontinence 82
3.3.2.2 Stone Management 87
3.3.2.3 Urological Endoscopes 87
3.3.2.4 Prostate Cancer Treatment 87
3.3.2.5 Nephrostomy 88
3.3.3 Coloplast 90
3.3.3.1 Urinary Catheter 90
3.3.3.2 Erectile Dysfunction 90
3.3.4 Cook Medical 91
3.3.4.1 Stone Management 91
3.3.4.2 Nephrostomy 92
3.3.5 Elekta 94
3.3.5.1 Prostate Cancer Treatment 94
3.3.6 Karl Storz 95
3.3.6.1 Urological Endoscopes 95
3.3.7 Olympus 96
3.3.7.1 Urological Endoscopes 96
3.4 CLINICAL TRIALS 98
3.4.1 Boston Scientific 98
3.4.1.1 Urinary Incontinence 98
3.4.1.2 BPH Treatment 99
3.4.1.3 Urological endoscopes 100
3.4.1.4 Nephrostomy 101
3.4.1.5 Erectile Dysfunction 102
3.4.2 C. R. Bard (Becton Dickinson) 103
3.4.2.1 Urinary Incontinence 103
3.4.2.2 Prostate Cancer Treatment 105
3.4.3 Coloplast 106
3.4.3.1 Urinary Incontinence 106
3.4.4 Cook Medical 109
3.4.4.1 Nephrostomy 109
3.4.5 Elekta 111
3.4.5.1 Prostate Cancer Treatment 111
3.4.6 Ethicon 113
3.4.6.1 Urinary Incontinence 113
3.4.7 Karl Storz 115
3.4.7.1 Stone Management 115
3.4.7.2 Urological Endoscopes 117
3.4.8 LABORIE 120
3.4.8.1 Urodynamics 120
3.4.9 Medline 122
3.4.9.1 Urinary Incontinence 122
3.4.10 Olympus 123
3.4.10.1 Stone Management 123
3.4.10.2 BPH Treatment 124
3.4.10.3 Urological Endoscopes 125
JAPAN UROLOGICAL DEVICE MARKET OVERVIEW 127
4.1 INTRODUCTION 127
4.2 CURRENCY EXCHANGE RATE 129
4.3 MARKET OVERVIEW 130
4.4 TREND ANALYSIS BY SEGMENT 136
4.5 DRIVERS AND LIMITERS 139
4.5.1 Market Drivers 139
4.5.2 Market Limiters 140
4.6 COMPETITIVE MARKET SHARE ANALYSIS 143
4.7 MERGERS AND ACQUISITIONS 150
4.8 COMPANY PROFILES 152
4.8.1 Boston Scientific 152
4.8.2 C. R. Bard (Becton Dickinson) 154
4.8.3 Coloplast 156
4.8.4 Cook Medical 157
4.8.5 Ethicon (Johnson & Johnson) 158
4.8.6 Karl Storz 159
4.8.7 LABORIE 160
4.8.8 Olympus 161
4.9 SWOT ANALYSIS 163
4.9.1 Boston Scientific 164
4.9.2 C. R. Bard (Becton Dickinson) 166
4.9.3 Coloplast 168
4.9.4 Cook Medical 169
4.9.5 Ethicon (Johnson & Johnson) 171
4.9.6 Karl Storz 172
4.9.7 LABORIE 173
4.9.8 Olympus 174
PROCEDURE NUMBERS 176
5.1 PROCEDURE OVERVIEW 176
5.2 URINARY INCONTINENCE PROCEDURES 181
5.2.1 Male Incontinence Management Procedures 183
5.2.2 Female Incontinence Management Procedures 185
5.3 PELVIC ORGAN PROLAPSE REPAIR 188
5.4 STONE MANAGEMENT PROCEDURES 190
5.4.1 ESWL Procedures 193
5.4.2 Transurethral Procedures 195
5.4.3 Ureteral Stent Placement Procedures 197
5.4.4 PCNL Procedures 199
5.5 BPH PROCEDURES 201
5.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 204
URINARY INCONTINENCE MANAGEMENT DEVICE MARKET 207
6.1 INTRODUCTION 207
6.2 MARKET OVERVIEW 209
6.3 MARKET ANALYSIS AND FORECAST 214
6.3.1 Total Urinary Catheter Market 214
6.3.1.1 Intermittent Catheter Market 217
6.3.1.2 Foley Catheter Market 219
6.3.1.3 Male External Catheter Market 221
6.3.2 Urethral Bulking Agent 223
6.3.3 Total Incontinence Management Device Market 224
6.3.3.1 Total Female Incontinence Sling Market 227
6.3.3.1.1 Transvaginal Tape Female Incontinence Sling Market 232
6.3.3.1.2 Transobturator Female Incontinence Sling Market 234
6.3.3.2 Total Male Implantable Incontinence Device Market 236
6.3.3.2.1 Male Incontinence Sling Market 241
6.3.3.2.2 Male Artificial Urinary Sphincter Market 243
6.4 DRIVERS AND LIMITERS 245
6.4.1 Market Drivers 245
6.4.2 Market Limiters 245
6.5 COMPETITIVE MARKET SHARE ANALYSIS 248
PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET 253
7.1 INTRODUCTION 253
7.2 MARKET OVERVIEW 255
7.3 MARKET ANALYSIS AND FORECAST 260
7.3.1 Total Pelvic Organ Prolapse Repair Device Market 260
7.3.2 Transvaginal Mesh Market 263
7.3.3 Sacrocolpopexy Mesh Market 265
7.4 DRIVERS AND LIMITERS 267
7.4.1 Market Drivers 267
7.4.2 Market Limiters 267
7.5 COMPETITIVE MARKET SHARE ANALYSIS 269
STONE MANAGEMENT DEVICE MARKET 272
8.1 INTRODUCTION 272
8.2 MARKET OVERVIEW 275
8.3 MARKET ANALYSIS AND FORECAST 281
8.3.1 ESWL Equipment Market 281
8.3.2 ISWL Equipment Market 284
8.3.3 Total Holmium Laser Market 286
8.3.3.1 Holmium Laser Equipment Market 289
8.3.3.2 Holmium Laser Fiber Market 291
8.3.4 Total Stone Fragment Retrieval Device Market 294
8.3.4.1 Nitinol Stone Fragment Retrieval Device Market 299
8.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 301
8.3.5 Ureteral Stent Market 303
8.3.6 Ureteral Guidewire Market 305
8.4 DRIVERS AND LIMITERS 307
8.4.1 Market Drivers 307
8.4.2 Market Limiters 308
8.5 COMPETITIVE MARKET SHARE ANALYSIS 310
BPH TREATMENT DEVICE MARKET 316
9.1 INTRODUCTION 316
9.1.1 Treatments 317
9.1.2 Comparison of TURP and Laser BPH Procedures 318
9.1.3 Emerging Technologies 318
9.2 MARKET OVERVIEW 320
9.3 MARKET ANALYSIS AND FORECAST 325
9.3.1 Total TURP Market 325
9.3.1.1 Monopolar Electrode Market 328
9.3.1.2 Bipolar Electrode Market 330
9.3.2 Total Laser BPH Market 332
9.3.2.1 Laser BPH Equipment Market 335
9.3.2.2 Laser BPH Fiber Market 337
9.3.3 UroLift® Market 339
9.3.4 Rezum® Market 342
9.4 DRIVERS AND LIMITERS 343
9.4.1 Market Limiters 344
9.5 COMPETITIVE MARKET SHARE ANALYSIS 347
ERECTILE DYSFUNCTION DEVICE MARKET 351
10.1 INTRODUCTION 351
10.1.1 Low Testosterone Pharmaceutical Delivery 352
10.2 MARKET OVERVIEW 353
10.3 MARKET ANALYSIS AND FORECAST 358
10.3.1 Inflatable Erectile Dysfunction Device Market 358
10.3.2 Malleable Erectile Dysfunction Device Market 360
10.3.3 Vacuum Erectile Dysfunction Device 362
10.4 DRIVERS AND LIMITERS 363
10.4.1 Market Drivers 363
10.4.2 Market Limiters 363
10.5 COMPETITIVE MARKET SHARE ANALYSIS 365
ABBREVIATIONS 368

Figure 1 1: Urological Device Market Share Ranking by Segment, Japan, 2019 3
Figure 1 2: Companies Researched in this Report, Japan, 2019 4
Figure 1 3: Factors Impacting the Urological Device Market by Segment, Japan 5
Figure 1 4: Recent Events in the Urological Device Market, 2017 – 2019 (1 of 2) 6
Figure 1 5: Recent Events in the Urological Device Market, 2017 – 2019 (2 of 2) 7
Figure 1 6: Urological Procedures Covered, Japan 8
Figure 1 7: Urological Device Markets Covered, Japan (1 of 2) 9
Figure 1 8: Urological Device Markets Covered, Japan (2 of 2) 10
Figure 1 9: Key Report Updates 11
Figure 1 10: Version History 11
Figure 3 1: Urinary Incontinence Treatments by Company (1 of 3) 55
Figure 3 2: Urinary Incontinence Treatments by Company (2 of 3) 56
Figure 3 3: Urinary Incontinence Treatments by Company (3 of 3) 57
Figure 3 4: Stone Management Devices by Company (1 of 3) 64
Figure 3 5: Stone Management Devices by Company (2 of 3) 65
Figure 3 6: Stone Management Devices by Company (3 of 3) 66
Figure 3 7: BPH Treatments by Company 75
Figure 3 8: Erectile Dysfunction Devices by Company 78
Figure 3 9: Class 2 Device Recall Auriga Laser System 79
Figure 3 10: Class 2 Device Recall Fiber Strippers and Cleavers 80
Figure 3 11: Class 2 Device Recall StarMedTec LightTrail Reusable Fibers 81
Figure 3 12: Class 2 Device Recall Malecot Catheter Set 81
Figure 3 13: Class 2 Device Recall Encore(TM) 26 Inflation Device 81
Figure 3 14: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter 82
Figure 3 15: Class 2 Device Recall Intermittent Catheters 82
Figure 3 16: Class 2 Device Recall leg bag 82
Figure 3 17: Class 2 Device Recall SURESTEP 83
Figure 3 18: Class 2 Device Recall PureWick External Catheter 83
Figure 3 19: Class 2 Device Recall SURESTEP Tray, BARDEX I.C. COMPLETE CARE, Urine Meter, Temperature STATLOCK Stabilization Device 83
Figure 3 20: Class 2 Device Recall BARD Irrigation Syringe, Rx Only, Sterile 84
Figure 3 21: Class 2 Device Recall Magic3 84
Figure 3 22: Class 2 Device Recall Optionvm Urinary Catheter. Male use only. Latex Free. Sterile, Rx only. 84
Figure 3 23: Class 3 Device Recall SureStep Tray, with AddaFoley 85
Figure 3 24: Class 2 Device Recall BARDEX 85
Figure 3 25: Class 3 Device Recall BARD Toomey Irrigation Syringe 70cc 85
Figure 3 26: Class 3 Device Recall Antibacterial Hydro Personal Catheter 85
Figure 3 27: Class 2 Device Recall Magic3 Intermittent Catheter with Sure Grip Hydrophilic Coated Silicone Coude tip 86
Figure 3 28: Class 2 Device Recall Magic3 Hydrophiliccoated Female Intermittent Catheter 86
Figure 3 29: Class 2 Device Recall Bard 100 LatexFree Urinary Drainage Bag with AntiReflux Chamber and Bard EXLok Sampling 86
Figure 3 30: Class 2 Device Recall Bard Dimension Stone Basket 87
Figure 3 31: Class 2 Device Recall CMax 87
Figure 3 32: Class 2 Device Recall Bard BrachySource Seed Implants 87
Figure 3 33: Class 2 Device Recall I125 CE Marked QuickLink Cartridges 88
Figure 3 34: Class 2 Device Recall Bard 88
Figure 3 35: Class 2 Device Recall XForce Nephrostomy Balloon Dilation Catheter Kit with Inflation Device 89
Figure 3 36: Class 2 Device Recall SelfCath Pediatric Catheter 90
Figure 3 37: Class 2 Device Recall Coloplast Conveen Urine Collection Leg Bag 90
Figure 3 38: Class 2 Device Recall Genesis Malleable Penile Prosthesis 90
Figure 3 39: Class 2 Device Recall StoneBreaker 91
Figure 3 40: Class 2 Device Recall OptiLite MultiUse Holmium Laser Fibers 91
Figure 3 41: Class 2 Device Recall Cook MultiUse Holmium Laser Fibers 92
Figure 3 42: Class 2 Device Recall Cook Bush 92
Figure 3 43: Class 2 Device Recall Aprima" Access Nonvascular Introducer Set 92
Figure 3 44: Class 2 Device Recall Ascend AQ 93
Figure 3 45: Class 2 Device Recall Oncentra Brachy 4.5 94
Figure 3 46: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 94
Figure 3 47: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 94
Figure 3 48: Class 2 Device Recall Oncentra Brachy treatment planning system 94
Figure 3 49: Class 2 Device Recall STORZ High Flow Insufflation Tubing (with filter) 95
Figure 3 50: Class 2 Device Recall Image1 SPIES XLINK Camera Control Unit (CCU) 95
Figure 3 51: Class 2 Device Recall Ureteroreno Videoscope & Fiberscope 96
Figure 3 52: Class 2 Device Recall A20975A: Working insert, with ramp, one way; A20976A: Bridge, one way; A20977A; Bridge, two way 96
Figure 3 53: Class 2 Device Recall Olympus High Freqency Resection Electrodes 96
Figure 3 54: Class 2 Device Recall Ureteroreno videoscope URFV2 and URFV2R 97
Figure 3 55: Class 2 Device Recall HF Cable WA00014A 97
Figure 3 56: Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx) 98
Figure 3 57: Mid-Urethral Sling Tensioning Trial (MUST) 98
Figure 3 58: Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence 99
Figure 3 59: Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP) 99
Figure 3 60: LithoVue Single Use Disposable Ureteroscope 100
Figure 3 61: Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope 100
Figure 3 62: Indwelling Stent Discoloration Project 101
Figure 3 63: Reduction of Stent Associated Morbidity by Minimizing Stent Material. 101
Figure 3 64: PROPPER Prospective Registry of Outcomes With Penile Prosthesis (PROPPER) 102
Figure 3 65: Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor 103
Figure 3 66: Foley Catheter vs a Self-contained Valved Urinary Catheter 103
Figure 3 67: Bladder Morphology Using 2 Different Catheter Designs 104
Figure 3 68: Outpatient Labor Induction With the Transcervical Foley Balloon 104
Figure 3 69: Medical and Economic Evaluation for Intermediate-risk Prostate Cancer (GETUGP05) 105
Figure 3 70: Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy 105
Figure 3 71: Product Evaluation of a Newly Developed Intermittent Catheter. 106
Figure 3 72: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers 106
Figure 3 73: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers 106
Figure 3 74: Virtue® European Study 107
Figure 3 75: Exploratory Study Investigating Urodynamic Parameters During Catheterisation 107
Figure 3 76: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence 107
Figure 3 77: The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY) 108
Figure 3 78: Do Hydrophilic Catheters Decrease Pain and Discomfort of a Patient During Urodynamic Study (HYDRUDS) 108
Figure 3 79: Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients (ESCALE) 108
Figure 3 80: Ureteral Stent Study 109
Figure 3 81: Impact Ureteral Sheath Design During Ureteroscopy 109
Figure 3 82: Optimization of Ureterolysis During Hysterectomy 110
Figure 3 83: Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure 110
Figure 3 84: Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy 111
Figure 3 85: Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy 111
Figure 3 86: Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer (SINFRA_PROST) 112
Figure 3 87: Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy (BRAPROST) 112
Figure 3 88: Combined Treatment for Mixed Incontinence (ESTEEM) 113
Figure 3 89: TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings 113
Figure 3 90: Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence 114
Figure 3 91: Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy 115
Figure 3 92: Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease 115
Figure 3 93: Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients. 116
Figure 3 94: Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease 116
Figure 3 95: Narrow Versus Wide Focal Zones for Shock Wave Lithotripsy of Renal Calculi 116
Figure 3 96: Are the Stone Density and Location Useful Parameters for Small Kidney Stones? 117
Figure 3 97: Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy 117
Figure 3 98: Comparison of Different Energy Sources During TUR-P 117
Figure 3 99: Effects of Flexible Ureteroscopy on Renal Blood Flow 118
Figure 3 100: A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting 118
Figure 3 101: Blue Light Cystoscopy With Cysview® Registry (BLCCR) 118
Figure 3 102: Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors 119
Figure 3 103: Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes 119
Figure 3 104: T-DOC® 5 Fr Pediatric Clinical Investigation 120
Figure 3 105: Air vs Water Catheters (AvW (Bonn)) 120
Figure 3 106: A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use 120
Figure 3 107: Portable Pves Study 121
Figure 3 108: Ambulatory Pessary Trial 121
Figure 3 109: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters 122
Figure 3 110: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters 122
Figure 3 111: Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery 123
Figure 3 112: Quality of Life in Kidney Stone Patients Undergoing Surgery 123
Figure 3 113: Prostate Vaporization Techniques in Canadian Hospital 124
Figure 3 114: Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode 124
Figure 3 115: Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy 125
Figure 3 116: Results of Safety Guidewire Use in Ureteroscopic Stone Surgery 125
Figure 3 117: Transurethral En Bloc Versus Standard Resection of Bladder Tumour 125
Figure 3 118: PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors (PK Button) 126
Figure 4 1: Currency Exchange Rate, 2019 129
Figure 4 2: Urological Device Market by Segment, Japan, 2016 – 2026 (US$M) 131
Figure 4 3: Urological Device Market by Segment, Japan, 2016 – 2026 (JP¥M) 132
Figure 4 4: Urological Device Market Growth by Segment, Japan, 2016 – 2026 137
Figure 4 5: Drivers and Limiters, Urological Device Market, Japan, 2019 142
Figure 4 6: Leading Competitors, Urological Device Market, Japan, 2019 148
Figure 4 7: SWOT Analysis, Boston Scientific (1 of 2) 164
Figure 4 8: SWOT Analysis, Boston Scientific (2 of 2) 165
Figure 4 9: SWOT Analysis, C. R. Bard (Becton Dickinson) (1 of 2) 166
Figure 4 10: SWOT Analysis, C. R. Bard (Becton Dickinson) (2 of 2) 167
Figure 4 11: SWOT Analysis, Coloplast 168
Figure 4 12: SWOT Analysis, Cook Medical (1 of 2) 169
Figure 4 13: SWOT Analysis, Cook Medical (2 of 2) 170
Figure 4 14: SWOT Analysis, Ethicon (Johnson & Johnson) 171
Figure 4 15: SWOT Analysis, Karl Storz 172
Figure 4 16: SWOT Analysis, LABORIE 173
Figure 4 17: SWOT Analysis, Olympus (1 of 2) 174
Figure 4 18: SWOT Analysis, Olympus (2 of 2) 175
Figure 5 1: Urological Procedures by Type, Japan, 2016 – 2026 177
Figure 5 2: Urinary Incontinence Procedures by Type, Japan, 2016 – 2026 181
Figure 5 3: Male Incontinence Management Procedures by Type, Japan, 2016 – 2026 183
Figure 5 4: Female Incontinence Management Procedures by Type, Japan, 2016 – 2026 186
Figure 5 5: Pelvic Organ Prolapse Repair Procedures by Type, Japan, 2016 – 2026 188
Figure 5 6: Stone Management Procedures by Type, Japan, 2016 – 2026 191
Figure 5 7: ESWL Procedures, Japan, 2016 – 2026 193
Figure 5 8: Transurethral Procedures by Type, Japan, 2016 – 2026 195
Figure 5 9: Ureteral Stent Placement Procedures, Japan, 2016 – 2026 197
Figure 5 10: PCNL Procedures, Japan, 2016 – 2026 199
Figure 5 11: BPH Procedures by Type, Japan, 2016 – 2026 202
Figure 5 12: Erectile Dysfunction Management Procedures by Type, Japan, 2016 – 2026 205
Figure 6 1: Urinary Incontinence Management Device Market by Segment, Japan, 2016 – 2026 (US$M) 210
Figure 6 2: Urinary Incontinence Management Device Market by Segment, Japan, 2016 – 2026 (JP¥M) 210
Figure 6 3: Urinary Catheter Market by Segment, Japan, 2016 – 2026 (US$M) 215
Figure 6 4: Urinary Catheter Market by Segment, Japan, 2016 – 2026 (JP¥M) 215
Figure 6 5: Intermittent Catheter Market, Japan, 2016 – 2026 217
Figure 6 6: Foley Catheter Market, Japan, 2016 – 2026 219
Figure 6 7: Male External Catheter Market, Japan, 2016 – 2026 221
Figure 6 8: Incontinence Management Device Market by Segment, Japan, 2016 – 2026 (US$M) 225
Figure 6 9: Incontinence Management Device Market by Segment, Japan, 2016 – 2026 (JP¥M) 225
Figure 6 10: Female Incontinence Sling Market by Type, Japan, 2016 – 2026 (US$M) 228
Figure 6 11: Female Incontinence Sling Market by Type, Japan, 2016 – 2026 (JP¥M) 228
Figure 6 12: Total Female Incontinence Sling Market, Japan, 2016 – 2026 230
Figure 6 13: Transvaginal Tape Female Incontinence Sling Market, Japan, 2016 – 2026 232
Figure 6 14: Transobturator Female Incontinence Sling Market, Japan, 2016 – 2026 234
Figure 6 15: Male Implantable Incontinence Device Market by Segment, U.S., 2015 – 2025 (US$M) 237
Figure 6 16: Male Implantable Incontinence Device Market by Segment, U.S., 2015 – 2025 (JP¥M) 237
Figure 6 17: Total Male Implantable Incontinence Device Market, Japan, 2016 – 2026 239
Figure 6 18: Male Incontinence Sling Market, Japan, 2016 – 2026 241
Figure 6 19: Male Artificial Urinary Sphincter Market, Japan, 2016 – 2026 243
Figure 6 20: Drivers and Limiters, Urinary Incontinence Management Device Market, Japan, 2019 247
Figure 6 21: Leading Competitors, Urinary Incontinence Management Device Market, Japan, 2018 251
Figure 7 1: Pelvic Organ Prolapse Repair Device Market by Segment, Japan, 2016 – 2026 (US$M) 256
Figure 7 2: Pelvic Organ Prolapse Repair Device Market by Segment, Japan, 2016 – 2026 (JP¥M) 256
Figure 7 3: Total Pelvic Organ Prolapse Repair Device Market, Japan, 2016 – 2026 261
Figure 7 4: Transvaginal Mesh Market, Australia, 2013 – 2023 263
Figure 7 5: Sacrocolpopexy Mesh Market, Japan, 2016 – 2026 265
Figure 7 6: Drivers and Limiters, Pelvic Organ Prolapse Repair Market, Japan, 2019 268
Figure 7 7: Leading Competitors, Pelvic Organ Prolapse Repair Market, Japan, 2019 270
Figure 8 1: Stone Management Device Market by Segment, Japan, 2016 – 2026 (US$M) 276
Figure 8 2: Stone Management Device Market by Segment, Japan, 2016 – 2026 (JP¥M) 277
Figure 8 3: ESWL Equipment Market, Japan, 2016 – 2026 282
Figure 8 4: ISWL Equipment Market, Japan, 2016 – 2026 284
Figure 8 5: Holmium Laser Market by Segment, Japan, 2016 – 2026 (US$M) 286
Figure 8 6: Holmium Laser Market by Segment, Japan, 2016 – 2026 (JP¥M) 287
Figure 8 7: Holmium Laser Equipment Market, Japan, 2016 – 2026 289
Figure 8 8: Holmium Laser Fiber Market, Japan, 2016 – 2026 292
Figure 8 9: Stone Fragment Retrieval Device Market by Segment, Japan, 2016 – 2026 (US$M) 295
Figure 8 10: Stone Fragment Retrieval Device Market by Segment, Japan, 2016 – 2026 (JP¥M) 295
Figure 8 11: Total Stone Fragment Retrieval Device Market, Japan, 2016 – 2026 297
Figure 8 12: Nitinol Stone Fragment Retrieval Device Market, Japan, 2016 – 2026 299
Figure 8 13: Stainless Steel Stone Fragment Retrieval Device Market, Japan, 2016 – 2026 301
Figure 8 14: Ureteral Stent Market, Japan, 2016 – 2026 303
Figure 8 15: Ureteral Guidewire Market, Japan, 2016 – 2026 305
Figure 8 16: Drivers and Limiters, Stone Management Device Market, Japan, 2018 309
Figure 8 17: Leading Competitors, Stone Management Device Market, Japan, 2019 314
Figure 9 1: BPH Treatment Device Market by Segment, Japan, 2016 – 2026 (US$M) 321
Figure 9 2: BPH Treatment Device Market by Segment, Japan, 2016 – 2026 (JP¥M) 321
Figure 9 3: TURP Market by Segment, Japan, 2016 – 2026 (US$M) 326
Figure 9 4: TURP Market by Segment, Japan, 2016 – 2026 (JP¥M) 326
Figure 9 5: Monopolar Electrode Market, Japan, 2016 – 2026 328
Figure 9 6: Bipolar Electrode Market, Japan, 2016 – 2026 330
Figure 9 7: Laser BPH Market by Segment, Japan, 2016 – 2026 (US$M) 333
Figure 9 8: Laser BPH Market by Segment, Japan, 2016 – 2026 (JP¥M) 333
Figure 9 9: Laser BPH Equipment Market, Japan, 2016 – 2026 335
Figure 9 10: Laser BPH Fiber Market, Japan, 2016 – 2026 337
Figure 9 11: UroLift Market, Japan, 2016 – 2026 340
Figure 9 12: Drivers and Limiters, BPH Treatment Device Market, Australia, 2018 346
Figure 9 13: Leading Competitors, BPH Device Market, Japan, 2019 349
Figure 10 1: Erectile Dysfunction Device Market by Segment, Japan, 2016 – 2026 (US$M) 354
Figure 10 2: Erectile Dysfunction Device Market by Segment, Japan, 2016 – 2026 (JP¥M) 354
Figure 10 3: Inflatable Erectile Dysfunction Device Market, Japan, 2016 – 2026 358
Figure 10 4: Malleable Erectile Dysfunction Device Market, Japan, 2016 – 2026 360
Figure 10 5: Drivers and Limiters, Erectile Dysfunction Device Market, Japan, 2019 364
Figure 10 6: Leading Competitors, Erectile Dysfunction Device Market, Japan, 2019 366

• BARD • Karl Storz
• Biolitec • LABORIE
• Boston Scientific • LISA Laser
• Coloplast • Lumenis
• Convergent • Medline
• Cook Medical • Olympus
• Create Medical • Richard Wolf
• Direx • Shibuya Corporation
• Dornier MedTech • Siemens
• EDAP TMS • Star Medtec
• EMS • Takai
• Hogy • Teleflex
• Hollister • Terumo
• Intersan • Trimedyne
• JMS • Urotech
• Johnson & Johnson